• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Observational study for evaluating associations between frailty, sarcopenia and prognosis in CKD patients

Research Project

Project/Area Number 18K07464
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 52010:General internal medicine-related
Research InstitutionTokyo Medical and Dental University

Principal Investigator

Naito Shotaro  東京医科歯科大学, 東京医科歯科大学病院, 准教授 (60584480)

Project Period (FY) 2018-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2020: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2019: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2018: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Keywordsサルコペニア / フレイル / 透析 / 末期腎不全 / 透析導入 / 慢性腎臓病
Outline of Final Research Achievements

The purpose of this study was to evaluate the actual status of sarcopenia/frail in patients with end-stage renal failure newly introduced to dialysis, to examine the development of complications (cardiovascular disease, infection, malignancy, etc.) and death as endpoints, to show the frequency of sarcopenia/frail in newly introduced dialysis patients in Japan, and to clarify the relationship between them and life expectancy. As of March 31, 2022, the mean age of the 117 enrolled patients was 68.6 years, and the mean creatinine was 8.64 mg/dL. Of the 117 patients, 26 (28.0%) met the criteria for sarcopenia out of 93 study subjects with no missing data. Of the 93 subjects with no missing data, 26 (28.0%) met the criteria for sarcopenia, and 76 (81.7%) met the criteria for frailty according to Fried.

Academic Significance and Societal Importance of the Research Achievements

サルコペニア・フレイルは、近年高齢者の生命予後に関与する因子としてその予防策が講じられている。また、慢性腎臓病は日本人の7人に1人に認める国民病と言われ、進行し末期腎不全に至ると生命維持のためには透析または腎移植が必要となり、高率に合併症を起こしQOLや生命予後も悪く、医療費もかかることから社会的にも問題と成っている。本研究では、末期腎不全に至った患者におけるサルコペニア・フレイルが高率であることを明らかにすることにより、慢性腎臓病患者に対しサルコペニア・フレイル予防のための早期介入の必要性を啓蒙することとなった点で意義があると考える。

Report

(5 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (2 results)

All 2022 2018

All Presentation (2 results) (of which Int'l Joint Research: 1 results,  Invited: 1 results)

  • [Presentation] 保存期CKD患者における利尿薬使用とサルコペニア2022

    • Author(s)
      内藤省太郎
    • Organizer
      第12回日本腎臓リハビリテーション学会学術集会
    • Related Report
      2021 Annual Research Report
    • Invited
  • [Presentation] Association Between Plasma Myostatin Levels and Loop Diuretic Use in Non-Dialysis-Dependent CKD Patients2018

    • Author(s)
      Ishikawa S, Naito S, Iimori S, Isobe K, Nomura N, Sahara E, Okada T, Rai T, Uchida S
    • Organizer
      Kidney Week 2018, American Society of Nephrology
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2018-04-23   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi